Document:

Exhibit 4.1

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

CLASS A COMMON STOCK PURCHASE WARRANT

 

INTUITIVE
MACHINES, INC.

 

	
    Warrant Shares: [_______]
	Initial Exercise Date: [_______], 202[●]

 

THIS CLASS A COMMON STOCK PURCHASE
WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____], 202[●]
(the “Termination Date”) but not thereafter, to subscribe for and purchase from Intuitive Machines, Inc., a Delaware
corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”)
of Class A common stock, par value $[●] per share, of the Company (the “Class A Common Stock”). The purchase
price of one share of Class A Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section 1. Definitions. Capitalized
terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the “Purchase
Agreement”), dated as of [●], by and among the Company and the purchasers signatory thereto.

 

Section 2. Exercise.

 

		(a)	Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in
whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the
Company (or such other office or agency that the Company may designate by notice in writing to the registered Holder at the address of
the Holder appearing on the books of the Company), as applicable, of a duly executed facsimile copy or PDF copy submitted by e-mail (or
e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i)
herein) following the date of exercise as aforesaid, the Holder shall deliver to the Company the aggregate Exercise Price for the shares
specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of
Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be
required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the
Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which
case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final
Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number
of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder
in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the
number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within
one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

     

     

    

 

		(b)	Exercise Price. The exercise price per share of Class A Common Stock under this Warrant shall be
$15.00, subject to adjustment hereunder (the “Exercise Price”). Notwithstanding the foregoing, at any time that the
Conversion Price (as defined in the Certificate of Designation) adjusts (or is otherwise lowered) pursuant to the terms of the Certificate
of Designation (each, an “Adjustment Time”, and such adjusted Conversion Price related thereto, each, an “Adjusted
Conversion Price”), if the Exercise Price then in effect immediately following such Adjustment Time is greater than such related
Adjusted Conversion Price, immediately following such Adjustment Time the Exercise Price then in effect shall automatically be lowered
by an amount equal to the difference between the Conversion Price immediately prior to the Adjustment Time and the Adjusted Conversion
Price immediately after the Adjustment Time. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 2(b),
the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased proportionately, so that after such
adjustment, the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate
Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).

 

		(c)	Cashless Exercise. If at any time after the six (6) month anniversary of the Closing Date, there
is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the Warrant
Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise”
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing ((A-B) multiplied
by (X)) by (A), where:

 

	 	(A) =	as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Class A Common Stock on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;
	 	 	 
	 	(B) =	the Exercise Price of this Warrant, as adjusted hereunder; and
	 	 	 
	 	(X) =	the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).

 

“Bid Price” means,
for any date, the price determined by the first of the following clauses that applies: (a) if the Class A Common Stock is then listed
or quoted on a Trading Market, the bid price of the Class A Common Stock for the time in question (or the nearest preceding date) on the
Trading Market on which the Class A Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Class A Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Class A Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Class A Common Stock are then reported on The Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Class A Common Stock so reported, or (d) in all other cases, the fair market value of a share of Class A Common Stock as determined by
an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

    2

     

    

 

“VWAP” means, for
any date, the price determined by the first of the following clauses that applies: (a) if the Class A Common Stock is then listed or quoted
on a Trading Market, the daily volume weighted average price of the Class A Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Class A Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from
9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Class A Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Class
A Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Class A Common Stock are then reported
in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Class A Common Stock so reported, or (d) in all other cases, the fair market value of a share of Class A Common Stock
as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

Notwithstanding anything herein to the
contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

 

		(d)	Mechanics of Exercise.

 

		(i)	Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased
hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s
balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if
the Company is then a participant in such system and there is an effective registration statement permitting the issuance of the Warrant
Shares to or resale of the Warrant Shares by the Holder, and otherwise by physical delivery of a certificate, (or reasonable evidence
of issuance by book entry of ownership of the Warrant Shares) registered in the Company’s share register in the name of the Holder
or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by
the Holder in the Notice of Exercise by the date that is the later of (i) the Standard Settlement Period after the delivery to the Company
of the Notice of Exercise, and (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company (such date, the
“Warrant Share Delivery Date”); provided, however, in any event, the Company shall not
be obligated to deliver Warrant Shares until it has received the aggregate Exercise Price therefor. Upon delivery of the Notice of Exercise,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the
aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and
(ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. The Company agrees
to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As
used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days,
on the Company’s primary Trading Market with respect to the Class A Common Stock as in effect on the date of delivery of the Notice
of Exercise.

 

		(ii)	Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the
Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares,
deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this
Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

		(iii)	Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the
Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date (subject to receipt of the aggregate Exercise Price
for the applicable exercise (other than in the case of a cashless exercise)), then the Holder will have the right to rescind such exercise
prior to the delivery of the Warrant Shares.

 

		(iv)	No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall
be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon
such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to
such fraction multiplied by the Exercise Price or round up to the next whole share.

 

    3

     

    

 

		(v)	Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder
for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses
shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all
fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares pursuant to the terms of this Warrant.

 

		(vi)	Closing of Books. The Company will not close its stockholder books or records in any manner which
prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

		(e)	Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent
that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with
the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates
(such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as
defined below). For purposes of the foregoing sentence, the number of shares of Class A Common Stock beneficially owned by the Holder,
its Affiliates and Attribution Parties shall include the number of shares of Class A Common Stock issuable upon exercise of this Warrant
with respect to which such determination is being made, but shall exclude the number of shares of Class A Common Stock which would be
issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company
(including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the
preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not
representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e)
applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any
Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable up to the Beneficial Ownership Limitation shall
be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s good faith
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises
of this Warrant that are not in compliance with the Beneficial Ownership Limitation. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability
for exercises of the Warrant that are not in compliance with the Beneficial Ownership Limitation. For purposes of this Section 2(e),
in determining the number of outstanding shares of Class A Common Stock, a Holder may rely on the number of outstanding shares of Class
A Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may
be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting
forth the number of shares of Class A Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within
two (2) Trading Days confirm orally and in writing to the Holder the number of shares of Class A Common Stock then outstanding. In any
case, the number of outstanding shares of Class A Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Class A Common Stock was reported. The “Beneficial Ownership Limitation” shall be 9.99%
of the number of shares of the Class A Common Stock outstanding immediately after giving effect to the issuance of shares of Class A Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds
9.99% of the number of shares of the Class A Common Stock outstanding immediately after giving effect to the issuance of shares of Class
A Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.
Any increase in the Beneficial Ownership Limitation will not be effective until the 61st
day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

    4

     

    

 

Section 3. Certain
Adjustments.

 

		(a)	Stock Dividends and Splits. If the Company at any time while this Warrant is outstanding: (i) pays
a stock dividend or otherwise makes a distribution or distributions on shares of its Class A Common Stock or any other equity or equity
equivalent securities payable in shares of Class A Common Stock (which, for avoidance of doubt, shall not include any shares of Class
A Common Stock issued by the Company upon exercise of this Warrant or any cash distributions), (ii) subdivides outstanding shares of Class
A Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Class A
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Class A Common Stock any shares of capital
stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number
of shares of Class A Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares of Class A Common Stock outstanding immediately after such event, and the number of shares issuable upon
exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.
Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination
of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the
case of a subdivision, combination or re-classification.

 

		(b)	Adjustment Upon Issuance of Class A Common Stock. If and whenever on or after the Closing Date,
the Company issues or sells, or in accordance with this Section 3(b) is deemed to have issued or sold, any shares of Class A Common
Stock (including the issuance or sale of shares of Class A Common Stock owned or held by or for the account of the Company, but
excluding shares of Class A Common Stock deemed to have been issued or sold by the Company in connection with any Exempt Issuance) for
a consideration per share (the “New Issuance Price”) less than a price (the “Applicable Price”)
equal to the Exercise Price in effect immediately prior to such issue or sale or deemed issuance or sale (the foregoing a “Dilutive
Issuance”), then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced to an amount equal
to the greater of (i) the Applicable Price immediately prior to the Dilutive Issuance less an amount equal to the difference between the
Applicable Price immediately prior to the Dilutive Issuance and the New Issuance Price and (ii) $11.50.

 

As used in this Warrant, the following
terms shall have the following meanings:

 

	
    
	(I)	“Common Stock Equivalents” means any securities of the Company which would entitle the holder thereof to acquire at any time Class A Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Class A Common Stock, and any securities of the Company that when paired with one or more other securities of the Company or another entity entitles the holder thereof to receive, Class A Common Stock.
	 	 	 
	 	(II)	“Convertible Securities” means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares of Class A Common Stock and any securities of the Company that when paired with one or more other securities of the Company or another entity entitles the holder thereof to receive, Class A Common Stock;
	 	 	 
	 	(III)	“Exempt Issuance” means the issuance of (a) any securities of the Company to employees, officers, directors, consultants, contractors, vendors or other agents of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities (as defined in the Purchase Agreement) and/or other securities exercisable or exchangeable for or convertible into shares of Class A Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Warrant to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, (c) the Underlying Shares (as defined in the Purchase Agreement), and (d) securities issued pursuant to any merger, acquisition or strategic transaction or partnership approved by a majority of the directors of the Company, provided that such securities are issued as “restricted securities” (as defined in Rule 144) and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds but any such Exempt Issuance shall not include a transaction in which the Company is issuing securities (x) primarily for the purpose of raising capital, including an at-the-market offering or (y) to an entity whose primary business is investing in securities.

 

    5

     

    

 

	 	(IV)	“Options” means any rights, warrants or options to subscribe for or purchase shares of Class A Common Stock or Convertible Securities; and
	 	 	 
	 	(V)	“Option Value” means the value of an Option based on the Black and Scholes Option Pricing model obtained from the “OV” function on Bloomberg determined as of (A) the Trading Day prior to the public announcement of the issuance of the applicable Option, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of the applicable Option as of the applicable date of determination, (ii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of (A) the Trading Day immediately following the public announcement of the applicable Option if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iii) the underlying price per share used in such calculation shall be the highest weighted average price of the Class A Common Stock during the period beginning on the Trading Day prior to the execution of definitive documentation relating to the issuance of the applicable Option and ending on (A) the Trading Day immediately following the public announcement of such issuance, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iv) a zero cost of borrow and (v) a 360 day annualization factor.

 

For purposes of determining the adjusted
Exercise Price under this Section 3(b), the following shall be applicable:

 

		(i)	Issuance of Options. If the Company in any manner grants or sells any Options after the Initial
Exercise Date and the lowest price per share for which one share of Class A Common Stock is issuable upon the exercise of any such Option
or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option is less
than the Applicable Price, then such share of Class A Common Stock shall be deemed to be outstanding and to have been issued and sold
by the Company at the time of the granting or sale of such Option for such price per share. For purposes of this Section 3(b)(i),
the “lowest price per share for which one share of Class A Common Stock is issuable upon the exercise of any such Options or upon
conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option” shall be equal to the
sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Class A Common
Stock upon the granting or sale of the Option, upon exercise of the Option and upon conversion, exercise or exchange of any Convertible
Security issuable upon exercise of such Option less any consideration paid or payable by the Company with respect to such one share of
Class A Common Stock upon the granting or sale of such Option, upon exercise of such Option and upon conversion exercise or exchange of
any Convertible Security issuable upon exercise of such Option. No further adjustment of the Exercise Price shall be made upon the actual
issuance of such shares of Class A Common Stock or of such Convertible Securities upon the exercise of such Options or upon the actual
issuance of such shares of Class A Common Stock upon conversion, exercise or exchange of such Convertible Securities.

 

		(ii)	Issuance of Convertible Securities. If the Company in any manner issues or sells any Convertible
Securities after the Initial Exercise Date and the lowest price per share for which one share of Class A Common Stock is issuable upon
the conversion, exercise or exchange thereof is less than the Applicable Price, then such share of Class A Common Stock
shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale of such Convertible
Securities for such price per share. For the purposes of this Section 3(b)(ii), the “lowest price per share for which one
share of Class A Common Stock is issuable upon the conversion, exercise or exchange thereof” shall be equal to the sum of the lowest
amounts of consideration (if any) received or receivable by the Company with respect to any one share of Class A Common Stock upon the
issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security less any consideration
paid or payable by the Company with respect to such one share of Class A Common Stock upon the issuance or sale of such Convertible Security
and upon conversion, exercise or exchange of such Convertible Security. No further adjustment of the Exercise Price shall be made upon
the actual issuance of such shares of Class A Common Stock upon conversion, exercise or exchange of such Convertible Securities, and if
any such issue or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of this Warrant has been
or is to be made pursuant to other provisions of this Section 3(b), no further adjustment of the Exercise Price shall be made by
reason of such issue or sale.

 

		(iii)	Change in Option Price or Rate of Conversion. If, after the Initial Exercise Date, the purchase
price provided for in any Options, the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any
Convertible Securities, or the rate at which any Convertible Securities are convertible into or exercisable or exchangeable for Class
A Common Stock increases or decreases at any time, the Exercise Price in effect at the time of such increase or decrease shall be adjusted
to the Exercise Price, which would have been in effect at such time had such Options or Convertible Securities provided for such increased
or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially
granted, issued or sold. For purposes of this Section 3(b)(iii), if the terms of any Option or Convertible Security that was outstanding
as of the Initial Exercise Date are increased or decreased in the manner described in the immediately preceding sentence, then such Option
or Convertible Security and the shares of Class A Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be
deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 3(b) shall be made
if such adjustment would result in an increase of the Exercise Price then in effect.

 

    6

     

    

 

		(iv)	Calculation of Consideration Received. In case any Option is issued in connection with the issue
or sale of other securities of the Company, together comprising one integrated transaction, (x) the Options will be deemed to have been
issued for the Option Value of such Options and (y) the other securities issued or sold in such integrated transaction shall be deemed
to have been issued or sold for the difference of (I) the aggregate consideration received by the Company less any consideration paid
or payable by the Company pursuant to the terms of such other securities of the Company, less (II) the Option Value. If any shares of
Class A Common Stock, Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration
other than cash received therefor will be deemed to be the net amount received by the Company therefor. If any shares of Class A Common
Stock, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration received
by the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in
which case the amount of consideration received by the Company will be the closing sale price of such publicly traded securities on the
date of receipt. If any shares of Class A Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving
entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed
to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares of Class
A Common Stock, Options or Convertible Securities, as the case may be. The fair value of any consideration other than cash or publicly
traded securities will be determined jointly by the Company and a majority in interest of the Securities then outstanding. If such parties
are unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the “Valuation Event”),
the fair value of such consideration will be determined within five (5) Business Days after the tenth (10th) day following the Valuation
Event by an independent, reputable appraiser jointly selected by the Company and a majority in interest of the Securities then outstanding.
The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such
appraiser shall be borne by the Company.

 

		(v)	Record Date. If the Company takes a record of the holders of Class A Common Stock for the purpose
of entitling them (A) to receive a dividend or other distribution payable in shares of Class A Common Stock, Options or in Convertible
Securities or (B) to subscribe for or purchase shares of Class A Common Stock, Options or Convertible Securities, then such record date
will be deemed to be the date of the issue or sale of the Class A Common Stock deemed to have been issued or sold upon the declaration
of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the
case may be.

 

		(vi)	Expiration or Termination of Options or Convertible Securities. Upon the expiration or termination
of any unexercised Option or unconverted or unexchanged Convertible Securities (or portion thereof) which resulted (either upon its original
issuance or upon a revision of its terms) in an adjustment to the Exercise Price pursuant to the terms of Section 3(b), the Exercise
Price shall be readjusted to such Conversion Price as would have obtained had such Option or Convertible Securities (or portion thereof)
never been issued.

 

		(c)	Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above,
if at any time after the Initial Exercise Date the Company grants, issues or sells any Common Stock Equivalents or rights to purchase
stock, warrants, securities or other property pro rata to the record holders of any class of shares of Class A Common Stock (the “Purchase
Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase
Rights which the Holder could have acquired if the Holder had held the number of shares of Class A Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no
such record is taken, the date as of which the record holders of shares of Class A Common Stock are to be determined for the grant, issue
or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Class A Common Stock as a result of such
Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever,
as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

		(d)	Pro Rata Distributions. During such time after the Initial Exercise Date as this Warrant is outstanding,
if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of
shares of Class A Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock
or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement
or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such
case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein
if the Holder had held the number of shares of Class A Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
Class A Common Stock are to be determined for the participation in such Distribution (provided, however, that,
to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Class A Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held
in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the
Beneficial Ownership Limitation).

 

    7

     

    

 

		(e)	Fundamental Transaction. If, at any time after the Initial Exercise Date while this Warrant is
outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company
with or into another Person, (ii) the Company (and all of its subsidiaries, taken as a whole), directly or indirectly, effects any sale,
lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of
related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another
Person) is completed pursuant to which holders of Class A Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Class A Common Stock, (iv) the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Class
A Common Stock or any compulsory share exchange pursuant to which the Class A Common Stock is effectively converted into or exchanged
for other securities, cash or property (other than as a result of a stock split, combination or reclassification of shares of Class A
Common Stock covered by Section 3(a)), or (v) the Company, directly or indirectly, in one or more related transactions consummates
a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or
more of the outstanding shares of Class A Common Stock (not including any shares of Class A Common Stock held by the other Person or other
Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement
or other business combination) or 50% or more of the voting power of the common equity of the Company (each a “Fundamental Transaction”),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Class A Common Stock of the
successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate
Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Class A Common
Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Class
A Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in
a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Class A Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below)
shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from
the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised
portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, that if holders of Class
A Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Class A Common
Stock will be deemed to have received common stock or ordinary shares of the Successor Entity (which Successor Entity may be the Company
following such Fundamental Transaction) in such Fundamental Transaction. “Black Scholes Value” means the value
of this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg determined as
of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate
corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated
Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day
volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately
following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such
calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of
any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning
on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable
Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request pursuant to this Section 3(e),
(D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and
the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately
available funds (or such other consideration) within the later of (i) five Business Days of the Holder’s election and (ii) the date
of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the
Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under
this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Class A Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the Exercise Price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Class A Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital
stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring
to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein.

 

    8

     

    

 

		(f)	Calculations. All calculations under this Section 3 shall be made to the nearest cent or
the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Class A Common Stock
deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Class A Common Stock (excluding treasury
shares, if any) issued and outstanding.

 

		(g)	Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to
this Section 3(a), the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased
proportionately so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares
shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on
exercise contained herein).

 

		(h)	Notice to Holder.

 

		(i)	Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision
of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price
after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring
such adjustment.

 

		(ii)	Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution
in whatever form) on the Class A Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of
the Class A Common Stock, (C) the Company shall authorize the granting to all holders of the Class A Common Stock rights or warrants to
subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company
shall be required in connection with any reclassification of the Class A Common Stock, any consolidation or merger to which the Company
(or any of its subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange
whereby the Class A Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be
delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register
of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x)
the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record
is not to be taken, the date as of which the holders of the Class A Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Class A Common
Stock of record shall be entitled to exchange their shares of the Class A Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided, that, notwithstanding the foregoing,
any notice delivery requirement hereunder shall also be deemed satisfied by filing or furnishing such communication with the Commission
via the EDGAR system; provided, further, that the failure to deliver such notice or any defect therein or in the delivery thereof
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
to the Holder in accordance with the terms of this Warrant constitutes, or contains, material, non-public information regarding the Company
or any of the subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form
8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective
date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

		(i)	Voluntary Adjustment By Company. Subject to the rules and regulations of the Trading Market, the
Company may at any time during the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise
Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.

 

    9

     

    

 

Section 4. Transfer
of Warrant.

 

		(a)	Transferability. Subject to compliance with any applicable securities laws and the conditions set
forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.

 

		(b)	New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof
at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are
to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which
may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant
or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the
Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

		(c)	Warrant Register. The Company shall register this Warrant, upon records to be maintained by the
Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company
may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.

 

		(d)	Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any
transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement
under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale
restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such
transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase
Agreement.

 

		(e)	Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that
it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account
and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or
any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

Section 5. Miscellaneous.

 

		(a)	No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting
rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i),
except as expressly set forth in Section 3.

 

		(b)	Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the
Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,
in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in
lieu of such Warrant or stock certificate.

 

    10

     

    

 

		(c)	Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or
the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be
exercised on the next succeeding Business Day.

 

		(d)	Authorized Shares.

 

		(i)	The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Class A Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of
any purchase rights under this Warrant (without regard to any limitation on exercise set forth herein). The Company further covenants
that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary
Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be
necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or
of any requirements of the Trading Market upon which the Class A Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).

 

		(ii)	Except and to the extent as waived or consented to by the Holder, the Company shall not by any action,
including, without limitation, amending its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of
all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without
limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body
having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

		(iii)	Before taking any action which would result in an adjustment in the number of Warrant Shares for which
this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

		(e)	Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation
of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.

 

		(f)	Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this
Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and
federal securities laws.

 

		(g)	Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder
on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without
limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any
provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall
be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate
proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers
or remedies hereunder.

 

    11

     

    

 

		(h)	Notices. Any notice, request or other document required or permitted to be given or delivered to
the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

		(i)	Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder
to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise
to any liability of the Holder for the purchase price of any Class A Common Stock or as a stockholder of the Company, whether such liability
is asserted by the Company or by creditors of the Company.

 

		(j)	Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including
recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages
would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

		(k)	Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and
obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and
the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time
to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

		(l)	Amendment. This Warrant may be modified, waived or amended or the provisions hereof waived with
the written consent of the Company and the Holder.

 

		(m)	Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner
as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable
law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

 

		(n)	Headings. The headings used in this Warrant are for the convenience of reference only and shall
not, for any purpose, be deemed a part of this Warrant.

 

********************

(Signature Page Follows)

 

    12

     

    

 

IN WITNESS WHEREOF, the parties hereto have caused
this Class A Common Stock Purchase Warrant to be duly executed by their respective authorized signatories as of the date first indicated
above.

 

	Inflection Point ACQUISITION CORP.	 	Address for Notice:
	 	 	 	34 East 51st Street, 5th Floor
	By:	 	 	New York, New York 10022
	Name: 	 Michael Blitzer	 	 
	Title:	Co-Chief Executive Officer	 	Email: 
	 	 	 	 
	With a copy to (which shall not constitute notice):	 	 
	 	 	 	 
	
    White & Case LLP

    1221 Avenue of the Americas

    New York, New York 10020
	 	 
	Attn: Joel L. Rubinstein	 	 
	Email: joel.rubinstein@whitecase.com	 	 

 

    13

     

    

 

IN WITNESS WHEREOF, the undersigned have caused
this Class A Common Stock Warrant to be duly executed by their respective authorized signatories as of the date first indicated above.

 

Name of Purchaser:

 

Signature of Authorized Signatory of Purchaser:

 

Name of Authorized Signatory:

 

Title of Authorized Signatory:

 

Email Address of Authorized Signatory:

 

Address for Notice to Purchaser:

 

Address for Delivery of Securities to Purchaser (if not same as address
for notice):

 

Subscription Amount:

 

Shares of Preferred Stock:

 

Warrant Shares:

 

Beneficial Ownership Blocker ☐
4.99% or ☐ 9.99%

 

EIN Number:

 

    14

     

    

 

EXHIBIT A

 

NOTICE OF EXERCISE

 

	To:	 
	 	 
	 	 
	 	Attn: 
	 	Email: 

 

(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form
of (check applicable box):

 

☐
in lawful money of the United States; or

 

☐
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).

 

(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:

 

	 	 	 
	 	 	 

The Warrant Shares shall be delivered to the following
DWAC Account Number:

	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

(4) Accredited Investor.
The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

[SIGNATURE OF HOLDER]

 

	Name of Investing Entity:___________________________________________________________________
	 
	Signature of Authorized Signatory of Investing Entity:________________________________________________
	 
	Name of Authorized Signatory:_________________________________________________________________
	 
	Title of Authorized Signatory:___________________________________________________________________
	 
	Date:__________________________________________________________________________________________

 

    15

     

    

 

EXHIBIT B

 

ASSIGNMENT FORM

 

(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 	 
	 	 	(Please Print)
	 	 	 
	Address:	 	 
	 	 	(Please Print)
	 	 	 
	Phone Number:	 	 
	 	 	 
	Email Address:	 	 
	 	 	 
	Dated: _______________ __, ______	 	 
	 	 	 
	Holder’s 

Signature:	 	 
	 	 	 
	Holder’s 

Address:	 	 

 

 

16Exhibit 10.1

 

SPONSOR SUPPORT AGREEMENT

 

This Sponsor Support Agreement
(this “Agreement”) is dated as of September 16, 2022, by and among Inflection Point Holdings LLC, a Cayman Islands limited
liability company (the “Sponsor”), Inflection Point Acquisition Corp., a Cayman Islands exempted company limited by
shares (which shall domesticate as a Delaware corporation prior to the Closing) (the “Purchaser”), and Intuitive Machines,
LLC, a Texas limited liability company (which shall convert into a Delaware limited liability company in connection with the Transactions)
(the “Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such
terms in the Business Combination Agreement (as defined below).

 

WHEREAS, as of the date hereof,
the Sponsor is the holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act) of
8,243,750 Purchaser Class B Ordinary Shares and 6,845,000 Purchaser Private Placement Warrants (collectively, the “Subject Securities”);

 

WHEREAS, contemporaneously with
the execution and delivery of this Agreement, the Purchaser and the Company have entered into the Business Combination Agreement (as it
may be amended, supplemented, restated or otherwise modified from time to time in accordance with its terms, the “Business Combination
Agreement”), dated as of the date hereof, pursuant to which, among other transactions, the Purchaser and the Company intend
to consummate a business combination; and

 

WHEREAS, as an inducement to
the Purchaser and the Company to enter into the Business Combination Agreement and to consummate the Transactions, the parties hereto
desire to agree to certain matters as set forth herein.

 

NOW, THEREFORE, in consideration
of the foregoing and the mutual agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto, each intending to be legally bound hereby, hereby agree as follows:

 

ARTICLE
I

SPONSOR SUPPORT AGREEMENT; COVENANTS

 

Section 1.1
Binding Effect of Business Combination Agreement. The Sponsor hereby acknowledges that it has read the Business Combination
Agreement and this Agreement and has had the opportunity to consult with its tax and legal advisors. The Sponsor shall be bound by, be
subject to and comply with Sections 6.06 (No Solicitation), 6.15 (Public Announcements) and 6.16 (Confidential Information)
of the Business Combination Agreement (and any relevant definitions contained in any such Sections) as if the Sponsor was an original
signatory to the Business Combination Agreement with respect to such provisions.

 

Section 1.2
No Transfer.

 

(a) Unless otherwise
deemed a Permitted Transfer (as defined below), during the period commencing on the date hereof and ending on the earliest of (a)
the Closing, (b) such date and time as the Business Combination Agreement shall be terminated in accordance with Section 8.01
(Termination) thereof (the earlier of (a) and (b), the “Expiration Time”) and (c) the liquidation of the
Purchaser, the Sponsor shall not, without the prior written consent of the Company, (i) sell, offer to sell, contract or agree to
sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, file
(or participate in the filing of) a registration statement with the SEC (other than the Proxy Statement/Registration Statement) or
establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16
of the Exchange Act, with respect to any Subject Securities owned by the Sponsor, (ii) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Securities owned by the
Sponsor or (iii) take any action in furtherance of any of the matters described in the foregoing clause (i) or (ii) (each, a
“Transfer”).

 

     

     

    

 

(b) “Permitted
Transfer” means any Transfer of Subject Securities (i) to (A) any officer or director of the Purchaser, the Company or the
Sponsor, (B) any Affiliates or family members of the officers or directors of the Purchaser, the Company or the Sponsor, or (C) any
direct or indirect partners, members or equity holders of the Sponsor or any related investment funds or vehicles controlled or
managed by such Persons or their respective Affiliates (including, for the avoidance of doubt, where such Person is a partnership,
to its general partner or a successor partnership or fund, or any other funds managed by such partnership); (ii) to a nominee or
custodian of a Person to whom a Transfer would be permitted under clause (i); (iii) in connection with any legal, regulatory or
other order; (iv) to a third party in connection with any non-redemption, backstop arrangement or other similar arrangement, (v) as
otherwise mutually agreed upon between the Sponsor, the Purchaser and the Company, or (vi) to the Purchaser, the Company or the
Sponsor; provided, however, that in the case of clauses (i) through (vi), as a precondition to such Transfer, such transferee
must enter into a written agreement with the Company and the Purchaser agreeing to assume all of the obligations under this
Agreement with respect to such Subject Securities and to be bound by the transfer restrictions set forth in this Agreement (to the
extent applicable); provided, further, that, no Transfer permitted under this Section 1.2 shall relieve Sponsor of its
obligations under this Agreement.

 

Section 1.3
New Shares. In the event that (a) any Purchaser Ordinary Shares, Purchaser Warrants or other equity securities of the Purchaser
are issued to the Sponsor after the date of this Agreement pursuant to any stock dividend, stock split, recapitalization, reclassification,
combination or exchange of, on or affecting the Purchaser Ordinary Shares or the Purchaser Warrants owned by the Sponsor or otherwise,
(b) the Sponsor purchases or otherwise acquires beneficial ownership of any Purchaser Ordinary Shares, Purchaser Warrants or other equity
securities of the Purchaser after the date of this Agreement, or (c) the Sponsor acquires the right to vote or share in the voting of
any Purchaser Ordinary Shares or other equity securities of the Purchaser after the date of this Agreement (such Purchaser Ordinary Shares,
Purchaser Warrants or other equity securities of the Purchaser, collectively, the “New Securities”), then such New
Securities acquired or purchased by the Sponsor shall be subject to the terms of this Agreement to the same extent as if they constituted
the Subject Securities owned by the Sponsor as of the date hereof.

 

Section 1.4
Closing Date Deliverables. On the Closing Date, the Sponsor shall deliver to the Purchaser and the Company a duly executed
copy of the A&R Registration Rights Agreement, the Lock-Up Agreement and the Earn Out Escrow Agreement.

 

Section 1.5 Agreements.

 

(a) At any meeting of
the Purchaser Shareholders, however called, or at any adjournment thereof, or in any other circumstance in which the vote, consent
or other approval of the Purchaser Shareholders is sought, the Sponsor shall (i) appear at each such meeting or otherwise cause all
of its Subject Securities, which are entitled to vote, to be counted as present thereat for purposes of calculating a quorum and
(ii) vote (or cause to be voted), or execute and deliver a written consent (or cause a written consent to be executed and delivered)
covering, all of its Subject Securities, which are entitled to vote:

 

(i)
in favor of each Transaction Proposal;

 

(ii)
against any Alternative Transaction or any proposal relating to an Alternative Transaction (in each case, other than the Transaction
Proposals);

 

    2

     

    

 

(iii)
against any merger agreement or merger (other than the Business Combination Agreement and the Transactions), consolidation, combination,
sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by the Purchaser;

 

(iv)
against any change in the business, management or board of directors of the Purchaser (other than in connection with the Transaction
Proposals or pursuant to the Business Combination Agreement or the Ancillary Documents); and

 

(v)
against any proposal, action or agreement that would (A) impede, interfere, frustrate, prevent or nullify any provision of this
Agreement, the Business Combination Agreement or the Transactions, (B) result in a breach in any respect of any covenant, representation,
warranty or any other obligation or agreement of the Purchaser under the Business Combination Agreement, (C) result in any of the conditions
set forth in Article VII (Closing Conditions) of the Business Combination Agreement not being fulfilled, (D) result in a breach
of any covenant, representation or warranty or other obligation or agreement of the Sponsor contained in this Agreement or (E) change
in any manner the dividend policy or capitalization of, including the voting rights of any class of capital stock of, the Purchaser.

 

The Sponsor hereby agrees
that the Sponsor shall not commit or agree to take any action inconsistent with the foregoing.

 

(b) The Sponsor shall
comply with, and fully perform all of its obligations, covenants and agreements set forth in, the Insider Letter (as defined below),
including the obligations of the Sponsor pursuant to Section 1 therein to not redeem any Purchaser Ordinary Shares owned by the
Sponsor in connection with the Transactions.

 

Section 1.6 No
Challenges. The Sponsor agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions
necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Purchaser, the
Company or any of their respective successors or directors (a) challenging the validity of, or seeking to enjoin the operation of,
any provision of this Agreement or (b) alleging a breach of any fiduciary duty of any person in connection with the evaluation,
negotiation or entry into this Agreement, the Business Combination Agreement or the Transactions. Notwithstanding anything herein to
the contrary, nothing in this Agreement shall limit or restrict the ability of the Sponsor to enforce its rights under this
Agreement or any other Ancillary Document to which such Person is a party or seek any other remedies with respect to any breach of
this Agreement or such other Ancillary Document by any other party hereto or thereto, including by commencing any action in
connection therewith.

 

    3

     

    

 

Section 1.7 Further
Assurances. The Sponsor shall take, or cause to be taken, all actions and do, or cause to be done, all things reasonably
necessary under applicable Laws to consummate the transactions contemplated hereby on the terms and subject to the conditions set
forth herein and the Transactions on the terms and subject to the conditions set forth in the Business Combination Agreement.

 

Section 1.8 No
Inconsistent Agreement. The Sponsor hereby represents and covenants that the Sponsor has not entered into, and shall not enter
into, any agreement that would restrict, limit or interfere with the performance of the Sponsor’s obligations hereunder.

 

Section 1.9 Insider
Letter. Neither the Sponsor nor the Purchaser shall amend, terminate or otherwise modify that certain letter agreement, dated as
of September 21, 2021, by and among the Purchaser, the Sponsor and certain of the Purchaser’s current and former officers and
directors (the “Insider Letter”) without the Company’s prior written consent.

 

Section 1.10 Waiver of
Anti-Dilution Provision. The Sponsor hereby (but subject to the consummation of the Transactions) waives (for itself, for its
successors, heirs and assigns), to the fullest extent permitted by law and the amended and restated memorandum and articles of
association of the Purchaser (as may be amended from time to time, the “Articles”), any and all anti-dilution
rights with respect to the rate that the Purchaser Class B Ordinary Shares held by the Sponsor convert into Purchaser Class A
Ordinary Shares in connection with the transactions contemplated by the Business Combination Agreement. The waiver specified in this Section
1.10 shall be applicable only in connection with the Transactions and the transactions contemplated by this Agreement (and any
Purchaser Class A Ordinary Shares, shares of Domesticated Purchaser Class A Common Stock or equity-linked securities issued in
connection with the Transactions and the transactions contemplated by this Agreement) and shall be void and of no force and effect
if the Business Combination Agreement shall be terminated for any reason.

 

Section 1.11 Sponsor
Indemnity. For a period of six (6) years after the Closing Date, the Company will indemnify, exonerate and hold harmless the
Sponsor and its members, managers and officers from and against any and all actions, causes of action, suits, claims, liabilities,
losses, damages and costs and out-of-pocket expenses in connection therewith (including reasonable attorneys’ fees and
expenses) (“Indemnified Liabilities”) incurred by the Sponsor on or after September 14, 2022, arising out of any
third-party action, cause of action, suit, litigation, investigation, inquiry, arbitration or claim relating to the transactions
contemplated by the Business Combination Agreement that names the Sponsor as a defendant (or co-defendant) arising from the
Sponsor’s ownership of equity interests of the Purchaser or its alleged, purported or actual control or ability to influence
the Purchaser; provided, that the foregoing shall not apply to (i) any Indemnified Liabilities to the extent arising out of any
breach by the Sponsor or its members, managers and officers of this Agreement or any other agreement between the Sponsor or its
members, managers and officers, on the one hand, and the Company or any of its subsidiaries, on the other hand or (ii) the willful
misconduct, gross negligence or fraud of the Sponsor or its members, managers and officers.

 

    4

     

    

 

Section 1.12 Sponsor
Earn-Out Shares.

 

(a) The Sponsor has
advised the board of directors of the Purchaser that it believes it is in the best interests of the Purchaser for the Sponsor to
subject a portion of its Domesticated Purchaser Class A Common Stock (received by the Sponsor upon exchange of the Purchaser Class A
Ordinary Shares in connection with the Domestication following the Sponsor Share Conversion) to the terms and conditions set forth
in the Earn Out Escrow Agreement and/or contribute a portion of its Domesticated Purchaser Class A Common Stock to the Purchaser in
the circumstances set forth in this Section 1.12. Accordingly, if (i) immediately prior to the Closing, the conditions set
forth in Section 7.02(f) (No Redemption) and Section 7.02(g) (Kingstown Investment) of the Business Combination
Agreement are not satisfied and (ii) the deferred underwriting commission paid to the underwriters of the IPO at the Closing is
greater than $5,770,625, then effective immediately prior to (and contingent upon) the Closing (and for the avoidance of doubt,
after the Domestication has occurred), the Sponsor shall cause an aggregate of 500,000 shares of Domesticated Purchaser Class A
Common Stock (which shares formerly constituted Purchaser Class B Ordinary Shares prior to the Domestication) (adjusted as
appropriate to reflect any stock splits, reverse stock splits, stock dividends (including any dividend or distribution of securities
convertible into Company Common Units), extraordinary cash dividend (which adjustment shall be subject to the reasonable mutual
agreement of the Purchaser and the Company), reorganization, recapitalization, reclassification, combination, exchange of shares or
other like change or transaction with respect to Domesticated Purchaser Class A Common Stock occurring on or after the Closing) to
be contributed to the Purchaser for no consideration or to be transferred to an escrow account (the “Escrow
Account”) maintained by an escrow agent reasonably acceptable to the Sponsor, the Company and the Purchaser (the
“Escrow Agent”), and such shares that are transferred to the Escrow Account (the “Sponsor Earn Out
Shares”) will thereafter be subject to the terms of this Section 1.12 and that certain stock escrow and earn-out
agreement, substantially in the form attached hereto as Exhibit A (the “Escrow Agreement”). At and after
the Closing, each of the Sponsor and the Purchaser shall use reasonable best efforts to cause the Escrow Agent and the other parties
to the Escrow Agreement to take all action necessary to give effect to this Section 1.12 and the Escrow Agreement.

 

(b) The Sponsor Earn Out
Shares shall be released from the Escrow Account and transferred to (i) the Sponsor if during the time period beginning on the date
that is one hundred fifty (150) days following the Closing Date and ending on the date that is the five (5) year anniversary of the
Closing Date (inclusive of the first and last day of such period) (the “Sponsor Earn Out Period”), (A) the Common
Share Price of the Domesticated Purchaser Class A Common Stock equals or exceeds $15.00 per share (the “Sponsor Earn Out
Trigger”), or (B) prior to the occurrence of the Sponsor Earn Out Trigger, there is a Change of Control that will result
in the holders of Domesticated Purchaser Class A Common Stock receiving a per share price (based on the value of the cash,
securities or in-kind consideration being delivered in respect of such Domesticated Purchaser Class A Common Stock, as determined in
good faith by the board of directors of Purchaser) equal to or in excess of $15.00 (adjusted as appropriate to reflect any stock
splits, reverse stock splits, stock dividends (including any dividend or distribution of securities convertible into shares of
Domesticated Purchaser Class A Common Stock), extraordinary cash dividend (which adjustment shall be determined by the Purchaser, in
its sole discretion), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change or
transaction with respect to shares of Domesticated Purchaser Class A Common Stock occurring on or after the Closing), and (ii) the
Purchaser, without any consideration for such transfer, if, upon the expiration of the Sponsor Earn Out Period, the Sponsor Earn Out
Shares have not become eligible for release pursuant to clause (i) above, following which release such Sponsor Earn Out
Shares shall be cancelled by the Purchaser and cease to exist.

 

    5

     

    

 

ARTICLE
II

REPRESENTATIONS AND WARRANTIES

 

Section 2.1
Representations and Warranties of the Sponsor. The Sponsor represents and warrants as of the date hereof to the Purchaser
and the Company as follows:

 

(a) Organization; Due
Authorization. The Sponsor is duly organized, validly existing and in good standing as a limited liability company under the
Laws of the jurisdiction in which it is incorporated, formed, organized or constituted, and the execution, delivery and performance
of this Agreement and the consummation of the transactions contemplated hereby are within the Sponsor’s limited liability
company powers and have been duly authorized by all necessary limited liability company actions on the part of the Sponsor. This
Agreement has been duly executed and delivered by the Sponsor and, assuming due authorization, execution and delivery by the other
parties to this Agreement, this Agreement constitutes a legally valid and binding obligation of the Sponsor, enforceable against the
Sponsor in accordance with the terms hereof (except as enforceability may be limited by bankruptcy Laws, other similar Laws
affecting creditors’ rights and general principles of equity affecting the availability of specific performance and other
equitable remedies). If this Agreement is being executed in a representative or fiduciary capacity, the Person signing this
Agreement has full power and authority to enter into this Agreement on behalf of the Sponsor.

 

(b) Ownership.
The Sponsor is the record and beneficial owner (as defined in Rule 13d-3 of the Exchange Act) of, and has good title to, all of the
Sponsor’s Subject Securities, and there exist no Liens or any other limitation or restriction (including any restriction on
the right to vote, sell or otherwise dispose of such Subject Securities (other than transfer restrictions under the Securities Act))
affecting any such Subject Securities, other than Liens pursuant to (i) this Agreement, (ii) the Purchaser’s Organizational
Documents, (iii) the Business Combination Agreement, (iv) the Insider Letter, (v) the Sponsor’s Organizational Documents, (vi)
agreements between the Sponsor and its members or (vii) any applicable securities Laws. The Sponsor’s Subject Securities are
the only equity securities in the Purchaser owned of record or beneficially by the Sponsor on the date of this Agreement, and none
of the Sponsor’s Subject Securities are subject to any proxy, voting trust or other agreement or arrangement with respect to
the voting of such Subject Securities, except as provided hereunder and under the Insider Letter. Other than the Purchaser Warrants
held by the Sponsor, the Sponsor does not hold or own any rights to acquire (directly or indirectly) any equity securities of the
Purchaser or any equity securities convertible into, or which can be exchanged for, equity securities of the Purchaser.

 

(c) No Conflicts.
The execution and delivery of this Agreement by the Sponsor does not, and the performance by the Sponsor of its obligations
hereunder will not, (i) conflict with or result in a violation of the organizational documents of the Sponsor or (ii) require any
consent or approval that has not been given or other action that has not been taken by any Person (including under any Contract
binding upon the Sponsor or the Sponsor’s Subject Securities), in each case, to the extent such consent, approval or other
action would prevent, enjoin or materially delay the performance by the Sponsor of its obligations under this Agreement.

 

(d) Litigation.
There are no Legal Proceedings pending against the Sponsor, or to the knowledge of the Sponsor threatened in writing against the
Sponsor, before (or, in the case of threatened Legal Proceedings, that would be before) any arbitrator or any Governmental
Authority, which in any manner challenges or seeks to prevent, enjoin or materially delay the performance by the Sponsor of its
obligations under this Agreement.

 

(e) Brokerage
Fees. Except as described on Section 5.15 (Broker’s Fees) of the Purchaser Disclosure Letter, no broker, finder,
investment banker or other Person is entitled to any brokerage fee, finders’ fee or other commission in connection with the
Transactions based upon arrangements made by the Sponsor, for which the Purchaser or any of its Affiliates may become liable.

 

(f) Acknowledgment.
The Sponsor understands and acknowledges that each of the Purchaser and the Company is entering into the Business Combination Agreement
in reliance upon the Sponsor’s execution and delivery of this Agreement.

 

    6

     

    

 

ARTICLE
III

MISCELLANEOUS

 

Section 3.1
Termination. This Agreement and all of its provisions shall terminate and be of no further force or effect upon the earliest
of (a) the Expiration Time, (b) the liquidation of the Purchaser and (c) the written agreement of the Sponsor, the Purchaser, and the
Company. Upon such termination of this Agreement, all obligations of the parties under this Agreement will terminate, without any liability
or other obligation on the part of any party hereto to any Person in respect hereof or the transactions contemplated hereby, and no party
hereto shall have any claim against another (and no person shall have any rights against such party), whether under contract, tort or
otherwise, with respect to the subject matter hereof; provided, however, that the termination of this Agreement shall not relieve any
party hereto from liability arising in respect of any breach of this Agreement prior to such termination. This ARTICLE III shall
survive the termination of this Agreement.

 

Section 3.2 Assignment.
This Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the parties hereto and their
respective heirs, successors and permitted assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder
will be assigned (including by operation of law) without the prior written consent of the parties hereto.

 

Section 3.3
Specific Performance. The parties hereto agree that irreparable damage may occur in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties hereto shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions of this Agreement in the chancery court or any other state or federal court within the State of Delaware, this
being in addition to any other remedy to which such party is entitled at law or in equity. In the event that any Action shall be brought
in equity to enforce the provisions of this Agreement, no party shall allege, and each party hereby waives the defense, that there is
an adequate remedy at law, and each party agrees to waive any requirement for the securing or posting of any bond in connection therewith.

 

Section 3.4
Amendment. This Agreement may not be amended, changed, supplemented, waived or otherwise modified or terminated, except
upon the execution and delivery of a written agreement executed by the Purchaser, the Company and the Sponsor.

 

Section 3.5
Miscellaneous. Sections 9.02 (Notices), 9.05 (Governing Law), 9.06 (Jurisdiction), 9.07 (Waiver
of Jury Trial), 9.09 (Severability), 9.11 (Entire Agreement), 9.12 (Interpretation), 9.13 (Counterparts)
and 9.15 (Waiver of Claims Against Trust) of the Business Combination Agreement are each hereby incorporated into this Agreement
(including any relevant definitions contained in any such Sections), mutatis mutandis.

 

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY
BLANK]

 

    7

     

    

 

IN WITNESS WHEREOF, the Sponsor, the
Purchaser and the Company have each caused this Agreement to be duly executed as of the date first written above.

 

	 	SPONSOR:
	 	 	 	 
	 	INFLECTION POINT HOLDINGS LLC
	 	 	 	 
	 	By: 	Kingstown Capital Management, L.P.,

 its manager
	 	 	 	 
	 	By: 	Kingstown Management GP LLC, general partner of Kingstown Management, L.P.
	 	 	 	 
	 	By: 	/s/ Michael Blitzer
	 	 	Name:	Michael Blitzer
	 	 	Title:	Managing Member

 

[Signature Page to Sponsor Support Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the Sponsor,
the Purchaser and the Company have each caused this Agreement to be duly executed as of the date first written above.

 

	 	PURCHASER:
	 	 	 
	 	INFLECTION POINT ACQUISITION CORP.
	 	 	 	 
	 	By: 	/s/ Michael Blitzer
	 	 	Name:	Michael Blitzer
	 	 	Title:	Co-Chief Executive Officer

 

[Signature Page to Sponsor Support Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the Sponsor,
the Purchaser and the Company have each caused this Agreement to be duly executed as of the date first written above.

 

	 	COMPANY:
	 	 
	 	INTUITIVE MACHINES, LLC
	 	 	 	 
	 	By: 	/s/ Stephen J. Altemus
	 	 	Name:	Stephen J. Altemus
	 	 	Title: 	President & CEO

 

[Signature Page to Sponsor Support Agreement]

 

     

     

    

 

Exhibit A

 

Stock Escrow and Earn-Out Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]